Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 40910 | 132.29 |
09:34 ET | 7770 | 132.465 |
09:36 ET | 7047 | 131.855 |
09:38 ET | 6699 | 132.1607 |
09:39 ET | 55144 | 133.89 |
09:41 ET | 23650 | 134.03 |
09:43 ET | 12575 | 134.74 |
09:45 ET | 67536 | 135.045 |
09:48 ET | 13512 | 135.305 |
09:50 ET | 13434 | 135.135 |
09:52 ET | 18913 | 134.86 |
09:54 ET | 7631 | 135.0898 |
09:56 ET | 5136 | 135.26 |
09:57 ET | 8969 | 135.365 |
09:59 ET | 10970 | 135.07 |
10:01 ET | 10730 | 134.99 |
10:03 ET | 10916 | 135.26 |
10:06 ET | 11844 | 135.71 |
10:08 ET | 15315 | 135.95 |
10:10 ET | 27288 | 135.885 |
10:12 ET | 50088 | 135.95 |
10:14 ET | 6927 | 135.845 |
10:15 ET | 6316 | 135.955 |
10:17 ET | 8804 | 136.27 |
10:19 ET | 9829 | 136.44 |
10:21 ET | 9689 | 136.74 |
10:24 ET | 12889 | 136.72 |
10:26 ET | 10355 | 136.68 |
10:28 ET | 17285 | 137.11 |
10:30 ET | 9416 | 137.11 |
10:32 ET | 19773 | 137.42 |
10:33 ET | 21421 | 137.65 |
10:35 ET | 25389 | 137.6485 |
10:37 ET | 27984 | 137.92 |
10:39 ET | 29848 | 137.44 |
10:42 ET | 10330 | 137.785 |
10:44 ET | 22820 | 138.05 |
10:46 ET | 60044 | 138.28 |
10:48 ET | 35518 | 138.56 |
10:50 ET | 24151 | 138.63 |
10:51 ET | 16480 | 138.75 |
10:53 ET | 18161 | 138.79 |
10:55 ET | 30929 | 138.93 |
10:57 ET | 11720 | 138.8366 |
11:00 ET | 18414 | 138.81 |
11:02 ET | 25231 | 138.635 |
11:04 ET | 20222 | 138.635 |
11:06 ET | 32280 | 138.705 |
11:08 ET | 8847 | 138.535 |
11:09 ET | 3387 | 138.62 |
11:11 ET | 5774 | 138.9 |
11:13 ET | 7508 | 138.635 |
11:15 ET | 29550 | 138.34 |
11:18 ET | 21195 | 138.06 |
11:20 ET | 10663 | 138.09 |
11:22 ET | 2128 | 138.075 |
11:24 ET | 7818 | 138.3 |
11:26 ET | 3718 | 138.08 |
11:27 ET | 6198 | 138.315 |
11:29 ET | 3584 | 138.305 |
11:31 ET | 12509 | 137.7311 |
11:33 ET | 3228 | 137.86 |
11:36 ET | 15180 | 137.72 |
11:38 ET | 5854 | 138 |
11:40 ET | 4057 | 137.75 |
11:42 ET | 9115 | 137.795 |
11:44 ET | 2507 | 137.9 |
11:45 ET | 2665 | 137.52 |
11:47 ET | 9430 | 137.58 |
11:49 ET | 6919 | 137.89 |
11:51 ET | 6461 | 138.3977 |
11:54 ET | 11215 | 138.475 |
11:56 ET | 8781 | 138.45 |
11:58 ET | 11092 | 138.66 |
12:00 ET | 4974 | 138.86 |
12:02 ET | 13782 | 138.7379 |
12:03 ET | 3185 | 138.8266 |
12:05 ET | 96498 | 139.14 |
12:07 ET | 18188 | 139.3785 |
12:09 ET | 16673 | 139.665 |
12:12 ET | 14633 | 139.69 |
12:14 ET | 13061 | 139.865 |
12:16 ET | 44247 | 140.4084 |
12:18 ET | 20711 | 140.58 |
12:20 ET | 18259 | 140.46 |
12:21 ET | 11447 | 140.48 |
12:23 ET | 8541 | 140.4335 |
12:25 ET | 11726 | 140.53 |
12:27 ET | 10640 | 140.2629 |
12:30 ET | 11340 | 140.39 |
12:32 ET | 34589 | 141.26 |
12:34 ET | 25006 | 141.025 |
12:36 ET | 52337 | 141.77 |
12:38 ET | 15552 | 141.83 |
12:39 ET | 41523 | 141.9597 |
12:41 ET | 16245 | 141.65 |
12:43 ET | 15609 | 141.575 |
12:45 ET | 16210 | 141.3 |
12:48 ET | 15418 | 141.7699 |
12:50 ET | 6275 | 141.45 |
12:52 ET | 7605 | 141.5 |
12:54 ET | 4861 | 141.45 |
12:56 ET | 18156 | 141.4228 |
12:57 ET | 6663 | 141.7464 |
12:59 ET | 24814 | 142.05 |
01:01 ET | 13255 | 141.85 |
01:03 ET | 6198 | 142 |
01:06 ET | 37556 | 142.7 |
01:08 ET | 17854 | 142.64 |
01:10 ET | 9289 | 142.49 |
01:12 ET | 7672 | 142.375 |
01:14 ET | 8164 | 142.4501 |
01:15 ET | 11070 | 142.44 |
01:17 ET | 12072 | 142.23 |
01:19 ET | 12264 | 142.07 |
01:21 ET | 14778 | 141.98 |
01:24 ET | 9946 | 142.3699 |
01:26 ET | 7954 | 142.3885 |
01:28 ET | 11038 | 142.02 |
01:30 ET | 10598 | 142.05 |
01:32 ET | 29981 | 141.75 |
01:33 ET | 18392 | 141.62 |
01:35 ET | 6684 | 141.741 |
01:37 ET | 10656 | 141.6399 |
01:39 ET | 15917 | 141.5201 |
01:42 ET | 8335 | 141.5 |
01:44 ET | 9601 | 141.454 |
01:46 ET | 20404 | 141.5601 |
01:48 ET | 10236 | 141.62 |
01:50 ET | 5727 | 141.4 |
01:51 ET | 5542 | 141.2001 |
01:53 ET | 40818 | 140.48 |
01:55 ET | 11284 | 140.375 |
01:57 ET | 9460 | 140.33 |
02:00 ET | 4279 | 140.245 |
02:02 ET | 4414 | 140.53 |
02:04 ET | 5844 | 140.51 |
02:06 ET | 4565 | 140.5884 |
02:08 ET | 2241 | 140.565 |
02:09 ET | 18765 | 140.085 |
02:11 ET | 21072 | 140.04 |
02:13 ET | 9957 | 140.17 |
02:15 ET | 5260 | 139.7 |
02:18 ET | 15023 | 139.41 |
02:20 ET | 6734 | 139.474 |
02:22 ET | 1201 | 139.4359 |
02:24 ET | 2575 | 139.5861 |
02:26 ET | 4616 | 139.56 |
02:27 ET | 5399 | 139.7353 |
02:29 ET | 3127 | 139.73 |
02:31 ET | 3952 | 139.7 |
02:33 ET | 5069 | 139.72 |
02:36 ET | 4227 | 139.775 |
02:38 ET | 10052 | 140.07 |
02:40 ET | 12016 | 140.1856 |
02:42 ET | 12297 | 139.87 |
02:44 ET | 5813 | 139.9789 |
02:45 ET | 3346 | 140.06 |
02:47 ET | 3080 | 140.07 |
02:49 ET | 4216 | 140.0762 |
02:51 ET | 2050 | 140.19 |
02:54 ET | 5139 | 140.22 |
02:56 ET | 6216 | 140.1 |
02:58 ET | 7318 | 140.05 |
03:00 ET | 7266 | 139.8793 |
03:02 ET | 5245 | 139.885 |
03:03 ET | 3769 | 140.1 |
03:05 ET | 4540 | 140.18 |
03:07 ET | 2750 | 140.13 |
03:09 ET | 2273 | 139.79 |
03:12 ET | 2300 | 140.08 |
03:14 ET | 9882 | 140.315 |
03:16 ET | 5463 | 140.445 |
03:18 ET | 4551 | 140.3822 |
03:20 ET | 7889 | 140.3315 |
03:21 ET | 2291 | 140.39 |
03:23 ET | 11883 | 140.345 |
03:25 ET | 4624 | 140.3 |
03:27 ET | 4926 | 140.59 |
03:30 ET | 9609 | 140.66 |
03:32 ET | 11206 | 140.5 |
03:34 ET | 6888 | 140.43 |
03:36 ET | 10261 | 140.52 |
03:38 ET | 8100 | 140.45 |
03:39 ET | 9590 | 140.405 |
03:41 ET | 9323 | 140.53 |
03:43 ET | 5339 | 140.72 |
03:45 ET | 11946 | 140.8 |
03:48 ET | 13002 | 140.7 |
03:50 ET | 12350 | 140.88 |
03:52 ET | 28656 | 140.9 |
03:54 ET | 16310 | 140.91 |
03:56 ET | 27338 | 140.8401 |
03:57 ET | 44409 | 141.02 |
03:59 ET | 67467 | 141.01 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 50.9B | -9.0x | --- |
ICON PLC | 26.0B | 38.7x | +4.68% |
Biogen Inc | 33.6B | 28.9x | -18.14% |
Biontech SE | 21.5B | 178.9x | --- |
Grifols SA | 6.5B | 78.4x | --- |
Charles River Laboratories International Inc | 11.4B | 26.2x | +15.57% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.9B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.52 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -9.0x |
Price/Sales (TTM) | 9.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.